These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1832460

  • 1. Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.
    Bevilacqua F, Marcello A, Toni M, Zavattoni M, Cusini M, Zerboni R, Gerna G, Palù G.
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):967-9. PubMed ID: 1832460
    [Abstract] [Full Text] [Related]

  • 2. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ, Tachedjian G, Doherty RR, Hayes K, Gust ID.
    J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
    [Abstract] [Full Text] [Related]

  • 3. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA, Greenspan D, Schiødt M, Drennan DP, Mills J.
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [Abstract] [Full Text] [Related]

  • 4. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS, Jacobson MA, Koehler JE, Follansbee SE, Drennan DP, Gooze L, Safrin S, Mills J.
    Ann Intern Med; 1989 May 01; 110(9):710-3. PubMed ID: 2522751
    [Abstract] [Full Text] [Related]

  • 5. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    Hardy WD.
    Am J Med; 1992 Feb 14; 92(2A):30S-35S. PubMed ID: 1531285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL, Nolan PE, Erlich KS, Ellis MN.
    Rev Infect Dis; 1989 Feb 14; 11(3):474-6. PubMed ID: 2546244
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA, Miller CH, Schrager LE, Crumpacker CS.
    N Engl J Med; 1989 Feb 02; 320(5):297-300. PubMed ID: 2536137
    [No Abstract] [Full Text] [Related]

  • 12. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK, Kauffman CL, Levy CS.
    Arch Dermatol; 1989 Nov 02; 125(11):1548-50. PubMed ID: 2554819
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.
    Safrin S.
    J Acquir Immune Defic Syndr (1988); 1992 Nov 02; 5 Suppl 1():S29-32. PubMed ID: 1602361
    [Abstract] [Full Text] [Related]

  • 15. Foscarnet effective in acyclovir-resistant herpes.
    Am Pharm; 1991 Nov 02; NS31(11):12. PubMed ID: 1836936
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M, Yasuda Y, Yabe H, Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S.
    J Med Virol; 2002 Sep 02; 68(1):99-104. PubMed ID: 12210436
    [Abstract] [Full Text] [Related]

  • 18. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C, Bianchi A.
    Pathol Biol (Paris); 1993 Feb 02; 41(2):172-7. PubMed ID: 8392160
    [Abstract] [Full Text] [Related]

  • 19. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates.
    Palù G, Gerna G, Bevilacqua F, Marcello A.
    Virus Res; 1992 Sep 01; 25(1-2):133-44. PubMed ID: 1329374
    [Abstract] [Full Text] [Related]

  • 20. Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Youle MM, Hawkins DA, Collins P, Shanson DC, Evans R, Oliver N, Lawrence A.
    Lancet; 1988 Aug 06; 2(8606):341-2. PubMed ID: 2899762
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.